258 related articles for article (PubMed ID: 26499318)
1. Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer.
Yeo I; Nookala P; Gordon I; Schulte R; Barnes S; Ghebremedhin A; Wang N; Yang G; Ling T; Bush D; Slater J; Patyal B
Radiat Oncol; 2015 Oct; 10():213. PubMed ID: 26499318
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.
Trofimov A; Nguyen PL; Coen JJ; Doppke KP; Schneider RJ; Adams JA; Bortfeld TR; Zietman AL; Delaney TF; Shipley WU
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):444-53. PubMed ID: 17513063
[TBL] [Abstract][Full Text] [Related]
3. Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing.
Dogan N; King S; Emami B; Mohideen N; Mirkovic N; Leybovich LB; Sethi A
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1480-91. PubMed ID: 14630288
[TBL] [Abstract][Full Text] [Related]
4. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer.
Chera BS; Vargas C; Morris CG; Louis D; Flampouri S; Yeung D; Duvvuri S; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):994-1002. PubMed ID: 19619961
[TBL] [Abstract][Full Text] [Related]
6. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
Mock U; Bogner J; Georg D; Auberger T; Pötter R
Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
[TBL] [Abstract][Full Text] [Related]
7. Prostate and seminal vesicle volume based consideration of prostate cancer patients for treatment with 3D-conformal or intensity-modulated radiation therapy.
Reddy NM; Nori D; Chang H; Lange CS; Ravi A
Med Phys; 2010 Jul; 37(7):3791-801. PubMed ID: 20831087
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes.
Yoo S; Wu QJ; Lee WR; Yin FF
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):935-42. PubMed ID: 20044214
[TBL] [Abstract][Full Text] [Related]
9. Pelvic Ewing sarcomas. Three-dimensional conformal vs. intensity-modulated radiotherapy.
Mounessi FS; Lehrich P; Haverkamp U; Willich N; Bölling T; Eich HT
Strahlenther Onkol; 2013 Apr; 189(4):308-14. PubMed ID: 23443613
[TBL] [Abstract][Full Text] [Related]
10. Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes.
Lomax AJ; Cella L; Weber D; Kurtz JM; Miralbell R
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):785-92. PubMed ID: 12573766
[TBL] [Abstract][Full Text] [Related]
11. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
Hein PA; Gladstone DJ; Bellerive MR; Hug EB
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous integrated boost plan comparison of volumetric-modulated arc therapy and sliding window intensity-modulated radiotherapy for whole pelvis irradiation of locally advanced prostate cancer.
Riou O; Regnault de la Mothe P; Azria D; Aillères N; Dubois JB; Fenoglietto P
J Appl Clin Med Phys; 2013 Jul; 14(4):4094. PubMed ID: 23835376
[TBL] [Abstract][Full Text] [Related]
13. RapidArc, intensity modulated photon and proton techniques for recurrent prostate cancer in previously irradiated patients: a treatment planning comparison study.
Weber DC; Wang H; Cozzi L; Dipasquale G; Khan HG; Ratib O; Rouzaud M; Vees H; Zaidi H; Miralbell R
Radiat Oncol; 2009 Sep; 4():34. PubMed ID: 19740429
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy.
Rana S; Cheng C; Zheng Y; Hsi W; Zeidan O; Schreuder N; Vargas C; Larson G
J Appl Clin Med Phys; 2014 May; 15(3):4611. PubMed ID: 24892333
[TBL] [Abstract][Full Text] [Related]
15. Development of a simultaneous boost IMRT class solution for a hypofractionated prostate cancer protocol.
Mott JH; Livsey JE; Logue JP
Br J Radiol; 2004 May; 77(917):377-86. PubMed ID: 15121701
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intensity-modulated radiotherapy and forward-planning dynamic arc therapy techniques for prostate cancer.
Metwaly M; Awaad AM; El-Sayed EM; Sallam ASM
J Appl Clin Med Phys; 2008 Oct; 9(4):37-56. PubMed ID: 19020481
[TBL] [Abstract][Full Text] [Related]
18. Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.
Corletto D; Iori M; Paiusco M; Brait L; Broggi S; Ceresoli G; Iotti C; Calandrino R; Fiorino C
Radiother Oncol; 2003 Feb; 66(2):185-95. PubMed ID: 12648791
[TBL] [Abstract][Full Text] [Related]
19. Complementary Relation Between the Improvement of Dose Delivery Technique and PTV Margin Reduction in Dose-Escalated Radiation Therapy for Prostate Cancer.
Utsunomiya S; Yamamoto J; Tanabe S; Oishi M; Satsuma A; Kaidu M; Abe E; Ohta A; Kushima N; Aoyama H
Pract Radiat Oncol; 2019 May; 9(3):172-178. PubMed ID: 30772440
[TBL] [Abstract][Full Text] [Related]
20. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
